Intraday Trading Highlights
On 24 Dec 2025, Gujarat Themis Biosyn demonstrated significant strength in trading activity, touching an intraday peak of Rs 441.15. This level represents a 7.76% increase from the previous close, marking one of the most pronounced single-day movements within the Pharmaceuticals & Biotechnology sector. The stock’s day change stood at 7.47%, outperforming the sector by 7.85% and the Sensex, which traded marginally lower by 0.03% at 85,495.07 points.
The stock’s upward momentum was supported by its position above key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical positioning often indicates sustained buying interest and a positive trend over multiple time horizons.
Recent Performance Context
Gujarat Themis Biosyn has been on a four-day consecutive gain streak, accumulating returns of 12.91% during this period. This recent run has contributed to the stock’s year-to-date performance of 43.17%, significantly outpacing the Sensex’s 9.41% gain over the same timeframe. Over longer horizons, the stock’s returns remain impressive, with a three-year return of 364.93% and a five-year return of 1155.83%, highlighting its sustained growth trajectory within the Pharmaceuticals & Biotechnology sector.
Market Environment
While Gujarat Themis Biosyn advanced sharply, the broader market exhibited a more subdued tone. The Sensex opened flat and traded slightly lower by 0.03%, remaining close to its 52-week high of 86,159.02, just 0.78% away. Mid-cap stocks led the market with the BSE Mid Cap index gaining 0.09%, indicating selective strength in certain segments. Gujarat Themis Biosyn’s outperformance relative to both the Sensex and its sector peers highlights its distinct trading activity amid a mixed market backdrop.
This week's revealed pick, a Large Cap from Public Banks with TARGET PRICE, is already showing movement! Get the complete analysis before it's too late.
- - Target price included
- - Early movement detected
- - Complete analysis ready
Technical Indicators and Moving Averages
The stock’s position above all major moving averages signals a strong technical setup. Trading above the 5-day and 20-day averages suggests short-term momentum, while remaining above the 50-day, 100-day, and 200-day averages indicates a longer-term positive trend. Such alignment across multiple moving averages often attracts technical traders and can contribute to sustained price strength.
Comparative Sector and Index Performance
Within the Pharmaceuticals & Biotechnology sector, Gujarat Themis Biosyn’s intraday gains of 7.76% stand out against the sector’s more modest movement. Over the past week, the stock’s return of 11.84% notably exceeds the Sensex’s 1.11% gain, and its one-month return of 9.16% also surpasses the Sensex’s 0.70%. These figures reflect the stock’s ability to maintain momentum relative to broader market indices and sector peers.
Long-Term Growth Perspective
Examining the stock’s performance over extended periods reveals a pattern of substantial appreciation. The 10-year return of 3827.54% far exceeds the Sensex’s 230.88% over the same period, underscoring Gujarat Themis Biosyn’s significant value creation for shareholders. This long-term growth is indicative of the company’s evolving position within the Pharmaceuticals & Biotechnology industry and its capacity to generate sustained returns.
Gujarat Themis Biosyn or something better? Our SwitchER feature analyzes this small-cap Pharmaceuticals & Biotechnology stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Summary of Trading Activity
Gujarat Themis Biosyn’s strong intraday performance today reflects a continuation of its recent upward trend. The stock’s ability to outperform both its sector and the broader market indices highlights its distinct trading dynamics. The alignment above key moving averages further supports the technical strength observed in the session.
While the broader market showed limited movement, Gujarat Themis Biosyn’s gains of 7.76% on the day and 12.91% over the last four sessions demonstrate notable resilience and momentum within the Pharmaceuticals & Biotechnology sector. This performance contributes to the stock’s impressive year-to-date return of 43.17%, well ahead of the Sensex’s 9.41% gain.
Investors and market participants will likely continue to monitor Gujarat Themis Biosyn’s price action and trading volumes as it maintains its position above critical technical levels.
Only Rs. 14,999 - Get MojoOne + Stock of the Week for 1 Year PLUS 18 Months FREE! Claim Your Free Year →
